Quest Diagnostics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $4.01B | $6.44B | $872.0M |
| FY2022 | $3.98B | $5.89B | $315.0M |
| FY2023 | $4.41B | $6.31B | $686.0M |
| FY2024 | $5.62B | $6.78B | $549.0M |
| FY2025 | $5.17B | $7.17B | $420.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $4.01B | $6.44B | $872.0M |
| FY2022 | $3.98B | $5.89B | $315.0M |
| FY2023 | $4.41B | $6.31B | $686.0M |
| FY2024 | $5.62B | $6.78B | $549.0M |
| FY2025 | $5.17B | $7.17B | $420.0M |